Akebia Therapeutics, Inc. (AKBA)
1.01
-0.05
(-4.72%)
USD |
NASDAQ |
May 18, 16:00
1.01
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Total Assets (Quarterly) : 362.52M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 3.450B |
| MannKind Corp. | 744.40M |
| United Therapeutics Corp. | 6.714B |
| Ardelyx, Inc. | 504.51M |
| Rhythm Pharmaceuticals, Inc. | 442.32M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 335.14M |
| Shareholders Equity (Quarterly) | 27.38M |
| Debt to Equity Ratio | 7.961 |
| Current Ratio | 1.400 |
| Net Debt Paydown Yield | -1.25% |